Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Sweet Earth Holdings's Debt-to-EBITDA or its related term are showing as below:
SEHCF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.57 Med: -0.33 Max: 0.68
Current: -0.17
During the past 6 years, the highest Debt-to-EBITDA Ratio of Sweet Earth Holdings was 0.68. The lowest was -2.57. And the median was -0.33.
SEHCF's Debt-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.67
vs SEHCF: -0.17
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Sweet Earth Holdings Debt-to-EBITDA Related Terms
Sweet Earth Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Sweet Earth Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sweet Earth Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sweet Earth Holdings Debt-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sweet Earth Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sweet Earth Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Sweet Earth Holdings (SEHCF) has a Debt-to-EBITDA of 0.74 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sweet Earth Holdings.
Is Sweet Earth Holdings' Debt-to-EBITDA too high?
Sweet Earth Holdings' current Debt-to-EBITDA is 0.74. The Drug Manufacturers industry median Debt-to-EBITDA is 1.67. Sweet Earth Holdings' value of 0.74 is 55.7% below this industry median. Overall, Sweet Earth Holdings has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Sweet Earth Holdings' Debt-to-EBITDA compare to ZTS?
Sweet Earth Holdings' Debt-to-EBITDA of 0.74 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.67. Sweet Earth Holdings' value of 0.74 is 55.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.67, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sweet Earth Holdings's current Debt-to-EBITDA of 0.74 is 55.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sweet Earth Holdings. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sweet Earth Holdings's current Debt-to-EBITDA is 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sweet Earth Holdings stock overvalued right now?
Sweet Earth Holdings (SEHCF) has a current Debt-to-EBITDA of 0.74. The stock's GF Value™ is $0.07, compared to a current price of $0.50 — trading 612.7% above its estimated fair value. The current Debt-to-EBITDA is 0.74 and 55.7% below the Drug Manufacturers industry median of 1.67. Sweet Earth Holdings' overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Sweet Earth Holdings (SEHCF), the current Debt-to-EBITDA is 0.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sweet Earth Holdings (SEHCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sweet Earth Holdings stock appears to be overvalued.
The current stock price of $0.50 is trading 612.7% above its estimated GF Value™ of $0.07.
Key valuation signals for SEHCF:
Debt-to-EBITDA: 0.74
GF Value™: $0.07 vs. price of $0.50 (612.7% above fair value)
Industry Position: 55.7% below the Drug Manufacturers median
No single metric tells the full story. See the SEHCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweet Earth Holdings Corp is engaged in cultivating and processing Hemp cannabidiols. The company operates in one reportable segment, the sale of hemp pre-roll and skin care products. The company's assets are located in Spain, Canada, and the USA.
38GF Score
Get the complete analysis for SEHCF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SEHCF has been successfully added to your 
